These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 31882480)
1. Transcriptomic Profiling of 3D Glioblastoma Tumoroids for the Identification of Mechanisms Involved in Anticancer Drug Resistance. Chaicharoenaudomrung N; Kunhorm P; Promjantuek W; Rujanapun N; Heebkaew N; Soraksa N; Noisa P In Vivo; 2020; 34(1):199-211. PubMed ID: 31882480 [TBL] [Abstract][Full Text] [Related]
2. Fabrication of 3D calcium-alginate scaffolds for human glioblastoma modeling and anticancer drug response evaluation. Chaicharoenaudomrung N; Kunhorm P; Promjantuek W; Heebkaew N; Rujanapun N; Noisa P J Cell Physiol; 2019 Nov; 234(11):20085-20097. PubMed ID: 30945284 [TBL] [Abstract][Full Text] [Related]
3. Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer. Sogawa C; Eguchi T; Namba Y; Okusha Y; Aoyama E; Ohyama K; Okamoto K Cells; 2021 Feb; 10(2):. PubMed ID: 33562088 [TBL] [Abstract][Full Text] [Related]
4. Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine. Valera ET; de Freitas Cortez MA; de Paula Queiroz RG; de Oliveira FM; Brassesco MS; Jabado N; Faury D; Bobola MS; Machado HR; Scrideli CA; Tone LG Childs Nerv Syst; 2009 Jan; 25(1):39-45. PubMed ID: 18946672 [TBL] [Abstract][Full Text] [Related]
5. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs. Jiang P; Mukthavaram R; Chao Y; Bharati IS; Fogal V; Pastorino S; Cong X; Nomura N; Gallagher M; Abbasi T; Vali S; Pingle SC; Makale M; Kesari S J Transl Med; 2014 Jan; 12():13. PubMed ID: 24433351 [TBL] [Abstract][Full Text] [Related]
6. Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models. Filipiak-Duliban A; Brodaczewska K; Kajdasz A; Kieda C Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163092 [TBL] [Abstract][Full Text] [Related]
7. Identification of novel drug resistance mechanisms by genomic and transcriptomic profiling of glioblastoma cells with mutation-activated EGFR. Kadioglu O; Saeed MEM; Mahmoud N; Azawi S; Mrasek K; Liehr T; Efferth T Life Sci; 2021 Nov; 284():119601. PubMed ID: 33991550 [TBL] [Abstract][Full Text] [Related]
8. Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma. Skaga E; Kulesskiy E; Fayzullin A; Sandberg CJ; Potdar S; Kyttälä A; Langmoen IA; Laakso A; Gaál-Paavola E; Perola M; Wennerberg K; Vik-Mo EO BMC Cancer; 2019 Jun; 19(1):628. PubMed ID: 31238897 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments. Shen Y; Grisdale CJ; Islam SA; Bose P; Lever J; Zhao EY; Grinshtein N; Ma Y; Mungall AJ; Moore RA; Lun X; Senger DL; Robbins SM; Wang AY; MacIsaac JL; Kobor MS; Luchman HA; Weiss S; Chan JA; Blough MD; Kaplan DR; Cairncross JG; Marra MA; Jones SJM Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19098-19108. PubMed ID: 31471491 [TBL] [Abstract][Full Text] [Related]
10. AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies. Godugu C; Patel AR; Desai U; Andey T; Sams A; Singh M PLoS One; 2013; 8(1):e53708. PubMed ID: 23349734 [TBL] [Abstract][Full Text] [Related]
11. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids. Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028 [TBL] [Abstract][Full Text] [Related]
13. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2. Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397 [TBL] [Abstract][Full Text] [Related]
14. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma. Huang S; Qi P; Zhang T; Li F; He X Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180 [TBL] [Abstract][Full Text] [Related]
16. Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition. Smith SJ; Wilson M; Ward JH; Rahman CV; Peet AC; Macarthur DC; Rose FR; Grundy RG; Rahman R PLoS One; 2012; 7(12):e52335. PubMed ID: 23272238 [TBL] [Abstract][Full Text] [Related]
17. Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile. Hägerstrand D; He X; Bradic Lindh M; Hoefs S; Hesselager G; Ostman A; Nistér M Neuro Oncol; 2011 Nov; 13(11):1178-91. PubMed ID: 21940738 [TBL] [Abstract][Full Text] [Related]
18. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
19. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance. Kwon SM; Kang SH; Park CK; Jung S; Park ES; Lee JS; Kim SH; Woo HG PLoS One; 2015; 10(10):e0140528. PubMed ID: 26466313 [TBL] [Abstract][Full Text] [Related]
20. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas. Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]